Stay updated on Endogenous Cushing's Treatment Clinical Trial
Sign up to get notified when there's something new on the Endogenous Cushing's Treatment Clinical Trial page.

Latest updates to the Endogenous Cushing's Treatment Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now lists Revision: v3.4.2 (replacing v3.4.1), a minor system update with no substantive changes to study data or content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. This appears to be a minor version update with no evident changes to study content or user functionality.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision label on the page was updated from v3.3.3 to v3.3.4. This is a technical update and does not affect study content or how the page is used.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Valencia (Spain) and British Columbia (Canada) locations, with an overall restructuring of the Locations section. Several per-location blocks in the U.S. and Canada (California, Maryland, Massachusetts, Michigan, New Mexico, New York, Ohio, Oregon, Pennsylvania) were removed or reorganized, and the revision note updated to v3.3.3.SummaryDifference0.9%

- Check100 days agoChange DetectedPublications section wording updated to clarify that publications are provided voluntarily by study entrants and that PubMed data are auto-filled; a new Revision: v3.3.2 tag was added.SummaryDifference0.1%

- Check107 days agoChange DetectedRemoved the notice about government funding and operating status. The core study details, eligibility criteria, and locations remain accessible.SummaryDifference0.3%

Stay in the know with updates to Endogenous Cushing's Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Endogenous Cushing's Treatment Clinical Trial page.